ArticleJournal of cellular and molecular medicine2013

Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitors.

Meng Ling Choong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.